Editorial: intended victim or innocent bystander? The liver in COVID-19-Authors' reply

Haijun Huang¹, Shanshan Chen^{1

2}, Hong Li^{1

3}, Xian-Long Zhou^{4

5}, Yining Dai¹, Jia Wu⁶, Jun Zhang⁷, Lina Shao⁸, Rong Yan¹, Mingshan Wang¹, Jiafeng Wang⁹, Yuexing Tu¹⁰, Minghua Ge⁹

Affiliations

¹ Department of Infectious Disease, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.
² Graduate School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
³ Medical College of Qingdao University, Qingdao, Shandong, China.
⁴ Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
⁵ Hubei Clinical Research Center for Emergency and Resuscitation, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
⁶ Department of Hepatobiliary and Pancreatic Surgery & Minimally Invasive Surgery, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College, Hangzhou, Zhejiang, China.
⁷ Department of Orthopaedic Surgery, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.
⁸ Department of Nephrology, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College, Hangzhou, Zhejiang, China.
⁹ Department of Head, Neck and Thyroid Surgery, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.
¹⁰ Department of Intensive Care Unit, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.

Editorial

Haijun Huang et al. Aliment Pharmacol Ther. 2020 Oct.

. 2020 Oct;52(7):1220-1221.

doi: 10.1111/apt.16046.

¹ Department of Infectious Disease, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.
² Graduate School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
³ Medical College of Qingdao University, Qingdao, Shandong, China.
⁴ Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
⁵ Hubei Clinical Research Center for Emergency and Resuscitation, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
⁶ Department of Hepatobiliary and Pancreatic Surgery & Minimally Invasive Surgery, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College, Hangzhou, Zhejiang, China.
⁷ Department of Orthopaedic Surgery, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.
⁸ Department of Nephrology, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College, Hangzhou, Zhejiang, China.
⁹ Department of Head, Neck and Thyroid Surgery, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.
¹⁰ Department of Intensive Care Unit, Zhejiang Provincial People's Hospital & People's Hospital affiliated of Hangzhou Medical College. Hangzhou, Zhejiang, China.

No abstract available

Comment in

Editorial: intended victim or innocent bystander? The liver in COVID-19.
Packer G, Bangash MN. Packer G, et al. Aliment Pharmacol Ther. 2020 Oct;52(7):1218-1219. doi: 10.1111/apt.16014. Aliment Pharmacol Ther. 2020. PMID: 33016557 No abstract available.

1. Packer G, Bangash MN. Editorial: intended victim or innocent bystander? The liver in COVID-19. Aliment Pharmacol Ther. 2020;52:1218-1219.
1. Huang H, Chen S, Li H, et al. The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan. Aliment Pharmacol Ther. 2020;52:1051-1059.
1. Ponziani FR, Del Zompo F, Nesci A, et al. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients. Aliment Pharmacol Ther. 2020. https://doi.org/10.1111/apt.15996
1. Kulkarni AV, Kumar P, Tevethia HV, et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;1-16. https://doi.org/10.1111/apt.15916
1. Phipps MM, Barraza LH, LaSota ED, et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large US cohort. Hepatology. 2020. Online ahead of print. https://doi.org/10.1002/hep.31404